Literature DB >> 28732743

Antimicrobial stewardship in the treatment of skin and soft tissue infections.

Julie A Gibbons1, Hayden L Smith2, Sudhir C Kumar1, Katherine Johnson Duggins3, Amanda M Bushman1, Jayme M Danielson4, William J Yost1, Jonathan J Wadle5.   

Abstract

BACKGROUND: Research on treating skin and soft tissue infections (SSTI) has shown improved patient outcomes with effective pharmaceutic prescribing. Antimicrobial stewardship programs can reduce consequences of broad-spectrum antimicrobial administration in SSTI treatment.
METHODS: Prospective and historic control data were collected during two 7-month periods. Intervention consisted of implementing a new SSTI evidence-based treatment algorithm and provider education, including calls and medical record notes targeted at physicians.
RESULTS: Of 412 patients, 76 and 86 were found eligible from the historic and intervention groups, respectively. The intervention group had a higher prevalence of appropriate antibiotic usage (33% vs 19%, respectively; P = .04). There was a lower median number of days from intravenous antibiotic therapy to oral conversion (3 vs 5; P < .0001) and a lower median number of days of antipseudomonal antibiotic use (3 vs 5; P = .03) in the intervention group, respectively. The intervention group also had fewer documented SSTI treatment complications (1% vs 8%, respectively; P = .04). The positive outcomes outlined demonstrate potential impacts made from the use of multidisciplinary antibiotic stewardship initiatives.
CONCLUSIONS: Appropriate use of antimicrobial agents under the direction of an antimicrobial stewardship program can lead to improved outcomes for patients being treated for SSTIs.
Copyright © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic; Antimicrobial; Cellulitis; Infection; Skin; Stewardship

Mesh:

Substances:

Year:  2017        PMID: 28732743     DOI: 10.1016/j.ajic.2017.05.013

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Treatment Duration and Associated Outcomes for Skin and Soft Tissue Infections in Patients With Obesity or Heart Failure.

Authors:  Claudia Ihm; Jesse D Sutton; Tristan T Timbrook; Emily S Spivak
Journal:  Open Forum Infect Dis       Date:  2019-05-07       Impact factor: 3.835

Review 2.  Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States.

Authors:  Keith S Kaye; Lindsay A Petty; Andrew F Shorr; Marya D Zilberberg
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

3.  Skin and soft tissue infections and current antimicrobial prescribing practices in Australian aged care residents.

Authors:  N J Bennett; N Imam; R J Ingram; R S James; K L Buising; A L Bull; C S Chen; K A Thursky; L J Worth
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

4.  Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections.

Authors:  Mark H Wilcox; Matthew Dryden
Journal:  J Antimicrob Chemother       Date:  2021-11-22       Impact factor: 5.790

5.  Early Switch From Intravenous to Oral Antibiotics in Skin and Soft Tissue Infections: An Algorithm-Based Prospective Multicenter Pilot Trial.

Authors:  Sandra Dellsperger; Simea Kramer; Michael Stoller; Annika Burger; Elio Geissbühler; Isabel Amsler; Anna Hirsig; Linda Weyer; Ursula Hebeisen; Philipp Aebi; Nicolas Burgherr; Fabienne Brügger; Edouard Chaix; Jérôme Salamoni; Sandra Glauser; Annina Elisabeth Büchi; Charles Béguelin; Gabriel Waldegg; Bernhard Kessler; Martin Egger; Parham Sendi
Journal:  Open Forum Infect Dis       Date:  2022-04-12       Impact factor: 4.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.